FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Automated Insulin Dosing Device System, Single Hormonal Control

PMA: P160017 · Supplement: S069 · Decision Aug 14, 2019
Classifications
1
FEI Numbers
16
Registration Numbers
16

Basic Information

Device Name
Automated Insulin Dosing Device System, Single Hormonal Control
Trade Name
MiniMed 670G System
PMA Number
P160017
Supplement Number
S069
Device Class
FDA Class 3
Product Code
OZP
Generic Name
Automated insulin dosing device system, single hormonal control
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
August 14, 2019
Date Received
July 15, 2019
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Automation of an inspection method at a contract manufacturer used during the packaging of components for the MiniLink REAL-Time transmitter, Guardian Link Transmitter, Guardian Link (3) Transmitter, Guardian Connect System, and iPro2 Recorder. The MiniLink REAL-Time transmitter is a component of the Minimed 530g System, Paradigm REAL-Time Revel System, and the Paradigm REAL-Time System. The Guardian Link Transmitter is a component of the Minimed 630G Insulin Pump System. The Guardian Link (3) Transmitter is a component of the MiniMed 670G System. The Guardian Link Transmitter is a component of the Medtronic MiniMed 630G Insulin Pump System. The Guardian Connect Transmitter is a component of the Guardian Connect System. The iPro2 Recorder is a component of the Ipro2 Continuous Glucose Monitoring System with Enlite Sensor.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OZP Automated Insulin Dosing Device System, Single Hormonal Control